These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22719025)

  • 21. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.
    Orenes-Piñero E; Hernández-Romero D; Jover E; de la Morena G; Valdés M; Marín F
    Med Chem; 2011 Jul; 7(4):275-85. PubMed ID: 21568880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of atrial fibrillation in hypertrophic cardiomyopathy.
    Hematpour K; Steinberg JS
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():44-8. PubMed ID: 17162270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertrophic cardiomyopathy in the elderly.
    Kubo T; Kitaoka H; Okawa M; Nishinaga M; Doi YL
    Geriatr Gerontol Int; 2010 Jan; 10(1):9-16. PubMed ID: 20102377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.
    Boonyasirinant T; Rajiah P; Setser RM; Lieber ML; Lever HM; Desai MY; Flamm SD
    J Am Coll Cardiol; 2009 Jul; 54(3):255-62. PubMed ID: 19589439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial capillary supply is limited in hypertrophic cardiomyopathy: a morphological analysis.
    Johansson B; Mörner S; Waldenström A; Stål P
    Int J Cardiol; 2008 May; 126(2):252-7. PubMed ID: 17532066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?
    Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical management of hypertrophic cardiomyopathy.
    Naghi JJ; Siegel RJ
    Rev Cardiovasc Med; 2010; 11(4):202-17. PubMed ID: 21389910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy: current understanding and treatment objectives.
    Soor GS; Luk A; Ahn E; Abraham JR; Woo A; Ralph-Edwards A; Butany J
    J Clin Pathol; 2009 Mar; 62(3):226-35. PubMed ID: 18930982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy.
    Maron BJ; Wolfson JK; Epstein SE; Roberts WC
    Z Kardiol; 1987; 76 Suppl 3():91-100. PubMed ID: 3433879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
    Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
    Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey.
    Cecchi F; Olivotto I; Betocchi S; Rapezzi C; Conte MR; Sinagra G; Zachara E; Gavazzi A; Rordorf R; Carnemolla G; Porcu M; Nistri S; Gruppillo P; Giampaoli S
    Am Heart J; 2005 Nov; 150(5):947-54. PubMed ID: 16290970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic obstruction to left ventricular outflow: the case for its existence in hypertrophic cardiomyopathy.
    Maron BJ; Epstein SE
    Z Kardiol; 1987; 76 Suppl 3():69-77. PubMed ID: 3324527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological therapy of atrial fibrillation.
    Grönefeld G; Bender B; Li YG; Hohnloser SH
    Thorac Cardiovasc Surg; 1999 Aug; 47 Suppl 3():334-8. PubMed ID: 10520763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].
    Maron BJ; Spirito P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):297-302. PubMed ID: 19791462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
    J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypertrophic cardiomyopathy].
    Scheffold T; Binner P; Erdmann J; Schunkert H;
    Herz; 2005 Sep; 30(6):550-7. PubMed ID: 16170688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial.
    Olivotto I; Hellawell JL; Farzaneh-Far R; Blair C; Coppini R; Myers J; Belardinelli L; Maron MS
    Circ Heart Fail; 2016 Mar; 9(3):e002764. PubMed ID: 26915375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of atrial fibrillation: an old option with new possibilities.
    Janko S; Dorwarth U; Hoffmann E
    Expert Opin Pharmacother; 2008 Apr; 9(6):913-25. PubMed ID: 18377335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.